Sexual Risk Behavior in HIV-Infected Injection Drug Users by Battegay, Manuel et al.
EDITORIAL COMMENTARY • CID 2004:38 (15 April) • 1175
E D I T O R I A L C O M M E N T A R Y
Sexual Risk Behavior in HIV-Infected
Injection Drug Users
Manuel Battegay,1 Heiner C. Bucher,1,2 and Pietro Vernazza3
1Division of Infectious Diseases and 2Basel Institute for Clinical Epidemiology, University Hospital Basel, and 3Division of Infectious Diseases, Cantonal Hospital,
St. Gallen, Switzerland
(See the article by Tun et al. on pages 1167–74)
Received 13 January 2004; accepted 13 January 2004;
electronically published 5 April 2004.
Reprints or correspondence: Dr. Manuel Battegay, Div. of
Infectious Diseases, University Hospital Basel, Petersgraben
4, CH-4031 Basel, Switzerland (mbattegay@uhbs.ch).
Clinical Infectious Diseases 2004; 38:1175–7
 2004 by the Infectious Diseases Society of America. All
rights reserved.
1058-4838/2004/3808-0022$15.00
Injection drug use continues to be a very
important mode of transmission of HIV
infection, particularly in Asia, Eastern Eu-
rope, and South America, where effective
needle-exchange programs and access to
antiretroviral therapy for injection drug
users (IDUs) are often limited [1, 2]. Still,
sexual intercourse remains the most im-
portant mode of HIV transmission world-
wide. IDUs may transmit HIV not only
by needle-sharing but also by unprotected
sexual intercourse. Likewise, they may ex-
pose themselves to HIV through high-risk
sexual behavior. In this context, IDUs may
exchange sex for drugs or money to sup-
port their drug use.
An important concern is the reports of
increased sexual risk-taking among HIV-
infected individuals, in particular among
IDUs receiving HAART. Nonetheless, only
a few prospective studies have investigated
risk behavior for HIV transmission among
IDUs. Active IDUs may not have the same
access to antiretroviral therapy as do HIV-
infected individuals from other risk
groups, may seek less medical advice, and
thus may forego opportunities for HIV-
infection counseling [3]. Hence, it is of
particular interest for caregivers and pol-
icy-makers to know whether HAART,
while dramatically improving the prog-
nosis of HIV-infected patients, has an in-
fluence on sexual risk behavior among
HIV-infected IDUs.
In this issue, Tun et al. [4] present a
study that examines changes in sexual risk
behavior in HIV-infected IDUs after ini-
tiation of HAART. This prospective study
investigated 190 HIV-infected IDUs who
initiated potent antiretroviral therapy be-
tween 1996 and 2000. An increase in CD4+
T cell count after initiation of therapy was
an independent predictor for engaging in
any sexual intercourse and engaging in un-
protected sexual intercourse (for which
the hazard ratio increased more than 3-
fold). An important finding was that
∼80% of the investigated study population
did not change their sexual and needle-
sharing behavior after the initiation of
HAART. Thus, engaging in unsafe sex
prior to initiation of HAART was associ-
ated with engaging in unprotected sex af-
ter initiation of HAART. However, once
adjusted for past behavior, an increase in
the CD4+ cell count remained the most
powerful predictor of engaging in unsafe
sex after the initiation of HAART [4].
The study by Tun et al. [4] is relevant
in several ways. Only a few studies report
longitudinal data on risk behaviors among
IDUs after initiation of HAART. So far,
results of recent studies are conflicting. For
example, a study of HIV-infected French
IDUs showed a significant decrease in sex-
ual risk behavior with receipt of HAART
[5]. A recent cross-sectional study from
the Swiss HIV Cohort Study investigating
4948 individuals, of whom approximately
one-third reported injection drug use,
showed that IDUs were more likely to re-
port engaging in unsafe sexual behavior
[6]. However, this study found no asso-
ciation between receipt of antiretroviral
therapy and achievement of optimal viral
suppression, on the one hand, and engag-
ing in unsafe sex, on the other. Other stud-
ies have found some increased sexual ac-
tivity among IDUs after HAART initiation
[7]. Differences between studies may be
linked to the type of assessment of risk
behavior that is used. In the study by Tun
et al. [4], risk behavior was measured by
trained study interviewers and by audio-
computer–assisted self-interviews, which
may have limited underreporting of un-
protected sex behavior and thus strength-
ens the validity of the results.
One of the particularities of the study
is the longitudinal evaluation, which in-
cluded risk assessment and measurement
of CD4+ cell counts prior to HAART in-
itiation, which allowed for an evaluation
of behavioral changes associated with
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therapy [4]. Analysis revealed that feeling
healthier per se was not associated with a
higher probability of engaging in risky
sexual behavior. Nevertheless, a better
health status would be a likely explanation.
In general, feeling well remains an im-
portant predictor of sexual behavior. In a
small Swiss study that used anonymous
questionnaires to evaluate sexual behavior
among HIV-infected individuals, good
subjective health status was associated
with increased sexual activity and with the
wish to conceive a child [8]. Also, the cu-
mulative probability of engaging in un-
protected sex may be increased just by
years of survival with this disease. Since
untreated HIV-infected individuals in the
cohort of 693 participants were not used
as a control in the study by Tun et al. [4],
it is impossible to rule out the possibility
that sexual risk behavior has not increased
generally in the group of HIV-infected
IDUs during the observation period.
A limitation of this study is the lack of
information about the nature of the IDUs’
partnerships—whether they were in a sta-
ble relationship or were occasional part-
ners, and, in particular, whether the part-
ner(s) were HIV infected or not. A recent
study from the Swiss HIV Cohort has
found differences in the rates that respon-
dents report engaging in unsafe sex with
stable partners and with occasional part-
ners (T. R. Glass, P.Vernazza, J. Young, and
the Swiss HIV Cohort Study Group, un-
published data). In this Swiss study, HIV-
infected individuals with stable HIV-
positive partners reported more frequently
engaging in unsafe sex, but, of major con-
cern, this was also reported by those with
occasional partners. It is notable that a
number of experts still recommend safe
sex practices for HIV-infected patients in
HIV-concordant partnerships to avoid
transmission of a resistant strain of the
virus, but, as yet, there is little evidence to
support this recommendation.
In her recent article, Latka [9] sum-
marized data that sexual risk behavior
depends on personal factors (e.g., per-
ceived vulnerability and protective behav-
iors), interpersonal factors (e.g., relation-
ship type and partner’s risk profile), social
factors (e.g., gender roles), and commu-
nity-level factors (e.g., access to methods
for prevention of infection and prevalence
of sexually transmitted pathogens within
a network). For female drug users, mul-
tiple factors may elevate their risk of sex-
ually acquired HIV infection [9]. Muga et
al. [10] found that, among women IDUs,
prevalence of HIV infection remained rel-
atively high between the late 1980s and
2001. The prevalence was more than twice
as high among women as among men
during the first 2 years of injection drug
use, and this difference persisted over
time. One explanation for the excess of
early prevalence among female IDUs may
be the high frequency of exchanging sex
for drugs [11].
HIV-infection counseling has a very im-
portant place [12]. In particular, outreach
interventions by peers helping each other
to understand the importance of safe sex
practices may be successful. Infectious dis-
eases physicians and specialized nurses, as
well as other care givers in the field of HIV/
AIDS care, have additional opportunities
to contribute to slowing the spread of the
epidemic. IDUs may benefit from person-
alized prevention-counseling models that
use exact goals and referral to drug treat-
ment and/or needle-exchange programs.
However, this is difficult for IDUs, because
they may not want to seek support and
medical advice on a regular basis. For
IDUs, factors that may strongly limit the
opportunities for behavioral interventions
are poverty and, partly, a disorganized life-
style. These factors may influence whether
IDUs take advantage of programs provid-
ing free access to sterile needles and other
harm-reduction strategies. Nevertheless,
specific measures, including counseling
and heroin-injection treatment programs
at clinics, might help to drastically reduce
the risk of HIV transmission due to in-
jection drug use. In a cohort of 145 HIV-
negative individuals among 172 IDUs en-
rolled in a heroin- injection treatment
program, only 1 experienced HIV sero-
conversion after a median follow-up of 20
months [13].
Sexual behavior is very difficult to
change, even when such behavior may
transmit a serious disease. It is important
to prospectively examine high-risk be-
havior in larger cohort studies and to in-
vestigate intervention strategies, such as
counseling.
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